Global Artificial Pancreas Devices Systems Market Growth 2023-2029

Global Artificial Pancreas Devices Systems Market Growth 2023-2029

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.

Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.

A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."

An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
LPI (LP Information)' newest research report, the “Artificial Pancreas Devices Systems Industry Forecast” looks at past sales and reviews total world Artificial Pancreas Devices Systems sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Pancreas Devices Systems sales for 2023 through 2029. With Artificial Pancreas Devices Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Pancreas Devices Systems industry.
This Insight Report provides a comprehensive analysis of the global Artificial Pancreas Devices Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Pancreas Devices Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Artificial Pancreas Devices Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Pancreas Devices Systems and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Pancreas Devices Systems.
The global Artificial Pancreas Devices Systems market size is projected to grow from US$ 87 million in 2022 to US$ 199.2 million in 2029; it is expected to grow at a CAGR of 199.2 from 2023 to 2029.
Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.
North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.
In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals
, followed by Clinics.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Pancreas Devices Systems market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segmentation by application
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Key Questions Addressed in this Report
What is the 10-year outlook for the global Artificial Pancreas Devices Systems market?
What factors are driving Artificial Pancreas Devices Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Artificial Pancreas Devices Systems market opportunities vary by end market size?
How does Artificial Pancreas Devices Systems break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.